Tax
Federal Tax (Current)
Vertex Pharmaceuticals Federal Tax (Current) remained flat by 0.0% to $169.78M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 3.7%, from $176.23M to $169.78M. Over 2 years (FY 2023 to FY 2025), Federal Tax (Current) shows a downward trend with a -13.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementIncome Statement
SectionTax
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2013
Last reportedQ4 2025
How to read this metric
Changes reflect shifts in domestic profitability and effective tax planning strategies.
Detailed definition
The portion of the total income tax provision that is currently payable to the national government based on the current...
Peer comparison
Standard tax disclosure for all U.S. public companies.
Metric ID:
msft_current_federal_tax_expenseHistorical Data
3 years
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $900.40M | $704.90M | $679.10M |
| YoY Change | — | -21.7% | -3.7% |
Range$679.10M – $900.40M
CAGR-13.2%
Avg YoY Growth-12.7%
Median YoY Growth-12.7%
Current Streak2+ years decline
Federal Tax (Current) at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's federal tax (current)?
- Vertex Pharmaceuticals (VRTX) reported federal tax (current) of $169.78M in Q4 2025.
- How has Vertex Pharmaceuticals's federal tax (current) changed year-over-year?
- Vertex Pharmaceuticals's federal tax (current) decreased by 3.7% year-over-year, from $176.23M to $169.78M.
- What is the long-term trend for Vertex Pharmaceuticals's federal tax (current)?
- Over 2 years (2023 to 2025), Vertex Pharmaceuticals's federal tax (current) has grown at a -13.2% compound annual growth rate (CAGR), from $900.40M to $679.10M.
- What does federal tax (current) mean?
- The amount of federal income tax currently owed for the period.